drugset / Trial / NCT00588406
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
Phase 3
Completed
95 enrolled
Northwell Health
AstraZeneca · collabJacobi Medical Center · collabNassau University Medical Center · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization.
Timeline
- Start
- 2007-09
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 2 mg | Inhaled |
| Background | Ipratropium | Small molecule | 2.5 mg | — |
| Background | Prednisone | Other / unclassified | 60 mg | Oral |
| Background | Salbutamol | Unknown | 2.5 mg | Inhaled |